Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs


Europe Approves GSK Rotarix

On Monday, the European Medicines Agency approved GSK's Rotarix (see article in the Financial Times). This comes right on the heels of the U.S. Food and Drug Administration's approval of Merck's rival vaccine Rotateq; both offer children protection against diarrheal disease caused by rotavirus, which kills nearly 500,000 children and hospitalizes two million more.